Clinical trial
Docetaxel in Treating Older Women With Metastatic Breast Cancer
NCT00104624 · UNICANCER, Other · Terminated
Key facts
| NCT number | NCT00104624 |
|---|---|
| Title | Docetaxel in Treating Older Women With Metastatic Breast Cancer |
| Official title | Phase II Trial Assessing the Impact on Instrumental and Daily Living Autonomy of a Chemotherapy With Biweekly Docetaxel in the Treatment of Metastatic Breast Cancer in Patients Over 70 |
| Lead sponsor | UNICANCER, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | docetaxel, quality-of-life assessment |
| Enrollment | 53 |
| Start date | May 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2008 |
| First posted | Mar 4, 2005 |
| Last update posted | Sep 4, 2013 |
| Countries | France, Italy, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: